Tullahoma Hma LLC
Tullahoma Hma LLC was paid $4.03M by Medicaid between Jan 2018 and Dec 2020, across 75 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.
TULLAHOMA, TN 37388
Next to other General Acute Care Hospital providers in Tennessee
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,152 | $1.33M | |
| 2019 | 45,531 | $1.51M | |
| 2020 | 39,298 | $1.18M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 14,064 | 12,677 | $1.14M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 7,991 | 6,959 | $779K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.5% | 2,343 | 1,971 | $301K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.2% | 4,150 | 3,619 | $208K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5.0% | 5,165 | 4,531 | $202K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.9% | 2,657 | 2,140 | $196K |
| 71045 | Radiologic examination, chest; single view | 3.2% | 2,980 | 2,519 | $130K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.2% | 3,390 | 2,888 | $130K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 3,628 | 3,054 | $103K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.4% | 2,206 | 2,046 | $97K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 1,848 | 1,714 | $91K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 1,330 | 1,149 | $86K |
63 more codes
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 1,284 | $81K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.8% | 2,973 | $71K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 9,255 | $41K |
| 80053 | Comprehensive metabolic panel | <1% | 9,598 | $36K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 485 | $36K |
| 87430 | <1% | 4,394 | $33K | |
| 84484 | <1% | 2,763 | $22K | |
| 94664 | <1% | 331 | $22K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 301 | $21K |
| 87400 | <1% | 5,429 | $20K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,786 | $17K |
| 59025 | Fetal non-stress test | <1% | 485 | $16K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 84 | $15K |
| 84703 | <1% | 2,328 | $14K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 265 | $12K |
| 81001 | <1% | 8,730 | $10K | |
| 83690 | <1% | 2,225 | $9K | |
| 87420 | <1% | 767 | $9K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,615 | $8K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 106 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 103 | $8K |
| 83880 | <1% | 889 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,343 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 273 | $7K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 390 | $5K |
| 83735 | <1% | 1,072 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 43 | $3K |
| 87040 | <1% | 370 | $3K | |
| 74018 | <1% | 26 | $2K | |
| 83655 | <1% | 110 | $2K | |
| 85027 | <1% | 460 | $2K | |
| 82550 | <1% | 497 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 846 | $1K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 71 | $1K |
| 82150 | <1% | 390 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 346 | $1K |
| 93017 | <1% | 12 | $936.65 | |
| 85007 | <1% | 450 | $904.14 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 607 | $779.26 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 127 | $615.24 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 789 | $577.31 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,923 | $517.06 |
| 87070 | <1% | 247 | $436.45 | |
| 85014 | <1% | 125 | $422.66 | |
| 85018 | <1% | 126 | $402.44 | |
| 87186 | <1% | 77 | $401.09 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 354 | $360.48 |
| 36600 | <1% | 14 | $249.02 | |
| 85610 | <1% | 222 | $245.29 | |
| 99156 | <1% | 43 | $244.98 | |
| 85730 | <1% | 143 | $180.77 | |
| 82803 | <1% | 15 | $107.44 | |
| 86140 | <1% | 26 | $94.74 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 125 | $84.25 |
| 96376 | <1% | 14 | $40.95 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 53 | $37.20 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 44 | $30.32 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 101 | $22.74 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 84 | $15.66 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 15 | $14.67 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 16 | $8.96 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 13 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.